Analyses of more than 3,000 genomes across 12 different kinds of cancer tumors have uncovered more than 100 genomic regions that may contain previously undiscovered drug targets, researchers report in two studies published in Nature Genetics. The findings support the theory that tumors can be classified based on molecular characteristics in addition to organ of origin. The researchers used data from the NIH-funded Cancer Genome Atlas, and 78 more papers are either slated for publication or are being drafted.

Related Summaries